↓ Skip to main content

Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules

Overview of attention for article published in Annals of Surgical Oncology, April 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
45 Mendeley
Title
Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules
Published in
Annals of Surgical Oncology, April 2015
DOI 10.1245/s10434-015-4486-3
Pubmed ID
Authors

Jennifer L. Marti, Vaidehi Avadhani, Luke A. Donatelli, Sayani Niyogi, Beverly Wang, Richard J. Wong, Ashok R. Shaha, Ronald A. Ghossein, Oscar Lin, Luc G. T. Morris, Allen S. Ho

Abstract

The Afirma gene expression classifier (GEC) is used to assess malignancy risk in indeterminate thyroid nodules (ITNs) classified as Bethesda category III/IV. Our objective was to analyze GEC performance at two institutions with high thyroid cytopathology volumes but differing prevalence of malignancy. Retrospective analysis of all ITNs evaluated with the GEC at Memorial Sloan Kettering Cancer Center (MSK; n = 94) and Mount Sinai Beth Israel (MSBI; n = 71). These institutions have differing prevalences of malignancy in ITNs: 30-38 % (MSK) and 10-19 % (MSBI). Surgical pathology was correlated with GEC findings for each matched nodule. Performance characteristics were estimated using Bayes Theorem. Patient and nodule characteristics were similar at MSK and MSBI. The GEC-benign call rates were 38.3 % (MSK) and 52.1 % (MSBI). Of the GEC-benign nodules, 8.3 % (MSK) and 13.5 % (MSBI) were treated surgically. Surgical pathology indicated that all of GEC-benign nodules were benign. Of the GEC-suspicious nodules, 60.0 % (MSK) and 61.7 % (MSBI) underwent surgery. Positive predictive values (PPVs) for GEC-suspicious results were 57.1 % (95 % CI 41.0-72.3) at MSK and 14.3 % (95 % CI 0.2-30.2) at MSBI. The estimated negative predictive values (NPVs) were 86-92 % at MSK and 95-98 % at MSBI. There were wide variations in the Afirma GEC-benign call rate, PPV, and NPV between MSBI (a comprehensive health system) and MSK (a tertiary referral cancer center), which had differing rates of malignancy in ITNs. The GEC could not routinely alter management in either institution. We believe that this assay would be expected to be most informative in practice settings where the prevalence of malignancy is 15-21 %, such that NPV >95 % and PPV >25 % would be anticipated. Knowing the prevalence of malignancy in ITNs at a particular institution is critical for reliable interpretation of GEC results.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 22%
Other 8 18%
Professor > Associate Professor 5 11%
Student > Bachelor 5 11%
Student > Ph. D. Student 3 7%
Other 7 16%
Unknown 7 16%
Readers by discipline Count As %
Medicine and Dentistry 23 51%
Biochemistry, Genetics and Molecular Biology 4 9%
Agricultural and Biological Sciences 2 4%
Immunology and Microbiology 2 4%
Nursing and Health Professions 1 2%
Other 3 7%
Unknown 10 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2017.
All research outputs
#18,571,001
of 23,001,641 outputs
Outputs from Annals of Surgical Oncology
#5,038
of 6,530 outputs
Outputs of similar age
#193,868
of 265,078 outputs
Outputs of similar age from Annals of Surgical Oncology
#53
of 84 outputs
Altmetric has tracked 23,001,641 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,530 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,078 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.